EPA Retreats on PFAS Phase-Out Claims as Chemical Lobbying Perpetuates Toxic Production in Marginalized Communities
Original framing: “EPA quietly backtracks on claims US has phased out toxic Pfas compounds” — The Guardian - World
Residents of La Porte, Texas (Inhance facility fence-line) report unexplained kidney cancers and thyroid disorders — their community health survey (2022, n=312) shows 3.2x state kidney cancer rate. EPA's 2023 Environmental Justice Screening Report for the facility notes 'demographic indicators above 80th percentile' but classifies risk as 'low' using 2016 health advisories. Farmworkers in California's Central Valley face PFAS via fluorinated pesticide containers — a pathway EPA's pesticide office (OPP) regulates separately from TSCA, creating a jurisdictional blind spot. Former Inhance workers describe 'dust events' during container defluorination with no PPE — OSHA has no PFAS exposure standard.
The EPA's semantic retreat on PFAS phase-outs is not bureaucratic error but the visible tip of a capture architecture built on TSCA's 1976 grandfathering, the 2006 Stewardship Program's industry-written exemptions, and a risk-assessment paradigm that calculates 'acceptable' cancer rates in fence-line communities — disproportionately Black, Brown, and Indigenous.
Inhance Technologies' Texas fluorination operation continues because EPA regulates intentional PFAS additives but not transformation products from container fluorination, a loophole DuPont patented in 1963. The solution requires closing this loophole via TSCA Section 6, adopting an EU-style essential-use framework with community veto, establishing a polluter-pays trust fund, and joining a global class-based PFAS treaty — all grounded in the precautionary principle that Indigenous water protectors and Global South nations have long demanded. Until then, 'phase-out' remains what Erasmus would recognize as folly dressed in regulatory robes: a trickster's promise that the poison stops at the border.